Tricuspid Regurgitation: How Will Valve Repair Change Our Practice?

Published: 25 May 2023

  • Views:

    Views Icon 4646

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Severe tricuspid regurgitation is an urgent global healthcare challenge, affecting over 70 million individuals worldwide. The associated adverse outcomes and burdensome symptoms demand effective solutions. While surgical intervention and medical therapy have been the traditional approaches, a new era has dawned with transcatheter repair emerging as a game-changing option.

 

In this on-demand version of the live broadcast, join Prof Ralph Stephan von Bardeleben (Heart Valve Center, Mainz, DE) as he chairs a panel of distinguished experts in the field; Dr Paul Sorajja (Abbott Northwestern Hospital, Minneapolis, US, Dr Ulrich Jorde (Montefiore Medical Center, New York, US), and Dr Gilbert Tang (Mount Sinai Health System, New York, US). Their collective expertise will illuminate the path towards identifying patients who will derive maximum benefit from repair-based approaches, surpassing the outcomes of surgery or medical therapy alone.

 

Stay at the forefront of innovation as these luminaries delve deep into the realm of tricuspid valve repair techniques. Uncover novel strategies, groundbreaking insights, and clinical data that will revolutionise your approach to patient care.

 

Want to find out more about the recent TRILUMINATE Pivotal Trial Results? In this short series of interviews, our faculty discuss the recent TRILUMINATE Pivotal Trial Results.

 

This broadcast is supported by an educational grant from Abbott.

Key Learning Objectives

  • Review existing real-world and RCT evidence on tricuspid valve repair
  • Assess relative effectiveness of existing modes of treatment for severe tricuspid regurgitation
  • Identify key patient groups who may benefit from device-based valve repair over surgical repair or medical therapy
  • Recall what recent advances in the field of device-based repair means for real-world practice
  • Apply emerging data and expert guidance to current practice

Target Audience

  • Cardiologists
  • Interventional Cardiologists
  • Surgeons
  • Heart Failure Specialists

More from this programme

Part 1

Welcome and Introduction

Prof Ralph Stephan von Bardeleben opens the broadcast by outlining the learning objectives that the audience can expect to achieve through the session.

1 session
Welcome and Introduction Watch now

Part 2

What Is the Current Need for TEER Today?

In this session, Dr Gilbert Tang examines the current demand for Transcatheter Edge-to-Edge Repair (TEER) in severe tricuspid regurgitation and explores existing approaches.

1 session
What Is the Current Need for TEER Today? Watch now

Part 3

What Is the Evidence for TEER?

In this session, Dr Paul Sorajja discusses the evidence supporting TEER for various cardiac conditions. He presents clinical and real-world data to analyse the effectiveness, safety, and outcomes of TEER procedures. 

1 session
What Is the Evidence for TEER? Watch now

Part 4

TEER in Context: View From the Heart Failure Clinic

Dr Ulrich Jorde provides insights into the role of TEER in managing heart failure patients, discussing its potential benefits and challenges from the perspective of a heart failure specialist in the clinic setting.

1 session
TEER in Context: View From the Heart Failure Clinic Watch now

Part 5

TR Patient Cases: TEER or Surgery?

Prof Ralph Stephan von Bardeleben presents two patient case studies that focus on severe tricuspid regurgitation (TR). The panel of experts engage in a thorough discussion to evaluate the optimal treatment approach for each case. The session aims to provide valuable insights into the decision-making process and strategies for managing TR effectively.

1 session
TR Patient Cases: TEER or Surgery? Watch now

Part 6

Discussion and Q&A

Prof Ralph Stephan von Bardeleben concludes the session by addressing some of the audience's questions, providing further clarification and insights on TR management.

1 session
Discussion and Q&A Watch now

About the episode

Prof Ralph Stephan von Bardeleben presents two patient case studies that focus on severe tricuspid regurgitation (TR). The panel of experts engage in a thorough discussion to evaluate the optimal treatment approach for each case. The session aims to provide valuable insights into the decision-making process and strategies for managing TR effectively.

Faculty Biographies

Ralph von Bardeleben

Ralph von Bardeleben

Head of the Centre of Structural Heart Disease Interventions and the Heart Valve Centre

Prof Ralph Stephan von Bardeleben is the Head of the Center of Structural Heart Disease Interventions and the Heart Valve Center in Mainz, Germany 

Prof Bardeleben is Past-President of the German working group on Echocardiography of the German Society of Cardiology and a member of several medical societies. He serves on the Clinical Program commission and at your region program of the ESC and is a reviewer for several peer-reviewed journals. Newly elected co-editor-in-chief of Echocardiography Journal.

He participates as PI, steering committee member and core laboratory in several medical device trials, including a German Federal Institute for Drugs and Medical Devices (BfArM)-approved first- or early-in-human medical device implant trials.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.